MERRIMACK PHARMACEUTICALS INC Quarterly Common Stock, Shares, Outstanding from Q4 2011 to Q1 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Merrimack Pharmaceuticals Inc quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2011 to Q1 2024.
  • Merrimack Pharmaceuticals Inc Common Stock, Shares, Outstanding for the quarter ending March 31, 2024 was 14.5M shares, a 1.94% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q1 2024 14.5M +277K +1.94% Mar 31, 2024 10-Q 2024-05-15
Q4 2023 14.4M +136K +0.96% Dec 31, 2023 10-Q 2024-05-15
Q3 2023 14.3M +911K +6.79% Sep 30, 2023 10-Q 2023-11-02
Q2 2023 14.3M +911K +6.79% Jun 30, 2023 10-Q 2023-08-03
Q1 2023 14.3M +845K +6.3% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 14.2M +805K +6% Dec 31, 2022 10-K 2024-03-07
Q3 2022 13.4M 0 0% Sep 30, 2022 10-Q 2022-11-03
Q2 2022 13.4M 0 0% Jun 30, 2022 10-Q 2022-08-04
Q1 2022 13.4M 0 0% Mar 31, 2022 10-Q 2022-05-05
Q4 2021 13.4M +30K +0.22% Dec 31, 2021 10-K 2023-03-09
Q3 2021 13.4M +30K +0.22% Sep 30, 2021 10-Q 2021-11-04
Q2 2021 13.4M +30K +0.22% Jun 30, 2021 10-Q 2021-08-05
Q1 2021 13.4M +30K +0.22% Mar 31, 2021 10-Q 2021-05-06
Q4 2020 13.4M 0 0% Dec 31, 2020 10-K 2022-03-09
Q3 2020 13.4M +17K +0.13% Sep 30, 2020 10-Q 2020-11-04
Q2 2020 13.4M +31K +0.23% Jun 30, 2020 10-Q 2020-08-07
Q1 2020 13.4M +37K +0.28% Mar 31, 2020 10-Q 2020-05-07
Q4 2019 13.4M +37K +0.28% Dec 31, 2019 10-K 2021-03-10
Q3 2019 13.4M +20K +0.15% Sep 30, 2019 10-Q 2019-11-12
Q2 2019 13.3M +6K +0.05% Jun 30, 2019 10-Q 2019-07-17
Q1 2019 13.3M 0 0% Mar 31, 2019 10-Q 2019-05-10
Q4 2018 13.3M 0 0% Dec 31, 2018 10-K 2020-03-12
Q3 2018 13.3M +69K +0.52% Sep 30, 2018 10-Q 2018-11-07
Q2 2018 13.3M -119M -89.9% Jun 30, 2018 10-Q 2018-08-07
Q1 2018 13.3M -119M -89.9% Mar 31, 2018 10-Q 2018-05-08
Q4 2017 13.3M +323K +2.48% Dec 31, 2017 10-K 2019-03-06
Q3 2017 13.3M -116M -89.7% Sep 30, 2017 10-Q 2017-11-08
Q2 2017 133M +3.75M +2.91% Jun 30, 2017 10-Q 2017-08-09
Q1 2017 132M +15.5M +13.3% Mar 31, 2017 10-Q 2017-05-10
Q4 2016 13M +1.43M +12.4% Dec 31, 2016 10-K 2018-03-12
Q3 2016 129M +14.3M +12.5% Sep 30, 2016 10-Q 2016-11-09
Q2 2016 129M +18.2M +16.4% Jun 30, 2016 10-Q 2016-08-04
Q1 2016 116M +7.03M +6.42% Mar 31, 2016 10-Q 2016-05-02
Q4 2015 11.6M -95.1M -89.1% Dec 31, 2015 8-K 2017-12-15
Q3 2015 115M +9.45M +8.94% Sep 30, 2015 10-Q 2015-11-09
Q2 2015 111M +6.29M +6.01% Jun 30, 2015 10-Q 2015-08-10
Q1 2015 109M +6.03M +5.83% Mar 31, 2015 10-Q 2015-05-07
Q4 2014 107M +4.17M +4.07% Dec 31, 2014 10-K 2016-02-26
Q3 2014 106M +3.38M +3.31% Sep 30, 2014 10-Q 2014-11-10
Q2 2014 105M +8.15M +8.46% Jun 30, 2014 10-Q 2014-08-11
Q1 2014 103M +7.41M +7.73% Mar 31, 2014 10-Q 2014-05-06
Q4 2013 103M +6.7M +6.99% Dec 31, 2013 10-K 2015-02-27
Q3 2013 102M +8.25M +8.77% Sep 30, 2013 10-Q 2013-11-08
Q2 2013 96.4M +2.82M +3.02% Jun 30, 2013 10-Q 2013-08-08
Q1 2013 95.9M +95.9M +805712% Mar 31, 2013 10-Q 2013-05-13
Q4 2012 95.8M +84M +710% Dec 31, 2012 10-K 2014-03-04
Q3 2012 94M Sep 30, 2012 10-Q 2012-11-14
Q2 2012 93.5M Jun 30, 2012 10-Q 2012-08-14
Q1 2012 11.9K* Mar 31, 2012 10-Q 2012-05-15
Q4 2011 11.8M Dec 31, 2011 10-K 2013-03-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.